About Proscia
Proscia is a digital and computational pathology company whose Concentriq platform manages pathology images and applies AI across the workflow from discovery through diagnosis. The vendor describes its portfolio as pathology AI for precision medicine, with purpose built solutions for biomarker research, clinical trials, companion diagnostics and case review.
The product serves two main audiences. Clinical laboratories use it for an immersive, operationally intelligent review experience at the point of case review, helping pathologists manage and interpret cases. Life sciences organizations, including biopharma companies, use it to turn tissue into biomarker insights and to move therapies through development and trials. A real world data offering is listed alongside, and Proscia also describes work with partners and a pathology AI portfolio that sits within the Concentriq platform. The site presents customer stories about moving whole organizations to digital pathology, and a recent announcement covers Unilabs adopting the platform across Europe.
Proscia states that Concentriq has been rated the highest digital pathology platform in both the United States and Europe in the Best in KLAS 2026 report. The company does not publish pricing, and buyers contact the vendor to discuss deployments for their laboratory or research program.